Brian Bloom
Brian Bloom is the CEO of Bloom Burton & Co., a leading life sciences underwriter in Canada. He is recognized for his insights into the biotechnology industry and has praised Francesco Bellini's achievements, particularly highlighting the monumental sale of BioChem Pharma as a benchmark in the biopharmaceutical field.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 6.00 | 0.08% | +0% | 38,005,238 | 31,487 | $1,700,000 | 1,408$ |
| Totals | 1 | 38,005,238 | 31,487 | $1,700,000 | 1,408$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Brian Bloom, chief executive officer of Bloom Burton & Co., commented on Zymeworks needing partner capital for the Theravance deal.
6
Canada:
In 2001, Dr. Bellini sold BioChem for $5.9-billion in a transaction that set the bar for the industry.
9